Boothbay Fund Management’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,198	Closed	-$92.3K	–	1936
2023 Q1	$92.3K	Sell	16,198 -1,425	-8%	-$8.12K	﹤0.01%	1709
2022 Q4	$106K	Buy	+17,623	New	+$106K	﹤0.01%	1527